Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Improvement Effect of Henggliejin on Fatty Liver in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver: a Multicenter, Prospective, Single Arm Clinical Study

NCT07198516 is registered in ClinicalTrials.gov with Fujian Medical University Union Hospital as lead sponsor.

NCT NCT07198516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07198516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Improvement Effect of Henggliejin on Fatty Liver in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver: a Multicenter, Prospective, Single Arm Clinical Study
Lead sponsor
Fujian Medical University Union Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
November 1, 2025
Completion date
December 31, 2026
Enrollment
149 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabete type 2, nafld